Webinars and Interactive Virtual Events


Tuesday, April 27, 2021

Wednesday, April 28, 2021

Women in Pathology – Leadership Development Event – Part II

Session Description: This 1-hour session will follow-up and build upon Part I of this Leadership Development Event. The Co-Chairs will guide discussion and assist participants in developing practical strategies for improvement of leadership skills and increased confidence when these skills are applied to real-life career situations.

Session Details


Friday, April 30, 2021

Past Webinars

February 24, 2021 – 12:00 PM CST – Register Here!
Nov 10, 2020 06:00 PM EST
November 11, 2020 | 6:00 PM EST

This image has an empty alt attribute; its file name is 1-3.png
This image has an empty alt attribute; its file name is 2-4.png
This image has an empty alt attribute; its file name is 3-2.png


Drs. Buja and Vander Heide will discuss up-to-date information regarding the pathobiology of COVID-19 based on their personal experiences conducting autopsies on COVID-19 positive patients in Houston, Texas and New Orleans, Louisiana, respectively. In addition, they will review information from autopsy series starting to emerge from other US cities as well as other countries. The speakers will present the actual evidence that COVID-19 is a systemic viral disease with multifaceted abnormalities of the lungs and the heart.

See the Questions and Answers!


Drs. Buja and Williamson will discuss and address the concerns surrounding the postmortem examination of COVID-19 decedents as well as the use of effective personal protective equipment while conducting these autopsies. In addition, the speakers will share their knowledge of the findings reported to date in decedents dying of or with COVID-19

Webinar Learning Objectives and Recommended Reading


Drs. Tsongalis and Fernandes will discuss the challenges of implementing Emergency Use Authorization (EUA) testing for the detection of SARS-CoV-2 RNA during the recent COVID-19 pandemic. In addition, they will focus on the implementation and clinical utility of these EUA tests for the detection of SARS-CoV-2 RNA at laboratories in the epicenter of the COVID-19 pandemic.